Wugengtian Pharmaceutical Group's market position was indeed somewhat awkward.
Although Wugengtian Pharmaceutical Group's drug prices were relatively high, its overall costs were also high, so its profit margin was actually relatively low.
However, because Wugengtian Pharmaceutical Group's drug prices were high, their effects were nothing particularly outstanding, and its brand strength was quite ordinary, the group's annual sales volume had been declining year by year.
Given this situation, the former five major distributors naturally did not care about Wugengtian Pharmaceutical Group's product allocation quotas.
In fact, aside from Ping'an Xingtian Group, the distributor for the Huabei region, which could complete the agreed sales targets, the other four distributors had been unable to meet their sales targets for years.
But things were different now!
Over the past few days, the five major distributors had already figured out the real effects of the Snowy Skin Series Products and naturally assessed their future prospects as well.
The five major distributors were unanimously optimistic about the prospects of the Snowy Skin Series Products!
Therefore, the five major distributors began fighting among themselves. They even expressed their willingness to sign huge performance-betting distribution agreements in order to secure exclusive distribution rights for the Snowy Skin Series Products.
However, wanting exclusive distribution rights for the Snowy Skin Series Products was simply a pipe dream.
An Wuyang was just as well aware of the prospects of the Snowy Skin Series Products. Otherwise, how could he have modeled their sales plan after Hermes' allocation mechanism?
It was naturally because An Wuyang knew very well that the Snowy Skin Series Products were exceptionally competitive, giving him the confidence to implement a bundled sales plan.
'Huabei Yang Yuxin: There's no need for everyone to keep arguing. The specific arrangements will still depend on President An.'
'Huabei Yang Yuxin: I only